Cargando…
In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis
PSA (Promastigote Surface Antigen) belongs to a family of membrane-bound and secreted proteins present in several Leishmania (L.) species. PSA is recognized by human Th1 cells and provides a high degree of protection in vaccinated mice. We evaluated humoral and cellular immune responses induced by a...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008367/ https://www.ncbi.nlm.nih.gov/pubmed/24786587 http://dx.doi.org/10.1371/journal.pone.0092708 |
_version_ | 1782314432486965248 |
---|---|
author | Chamakh-Ayari, Rym Bras-Gonçalves, Rachel Bahi-Jaber, Narges Petitdidier, Elodie Markikou-Ouni, Wafa Aoun, Karim Moreno, Javier Carrillo, Eugenia Salotra, Poonam Kaushal, Himanshu Negi, Narender Singh Arevalo, Jorge Falconi-Agapito, Francesca Privat, Angela Cruz, Maria Pagniez, Julie Papierok, Gérard-Marie Rhouma, Faten Bel Haj Torres, Pilar Lemesre, Jean-Loup Chenik, Mehdi Meddeb-Garnaoui, Amel |
author_facet | Chamakh-Ayari, Rym Bras-Gonçalves, Rachel Bahi-Jaber, Narges Petitdidier, Elodie Markikou-Ouni, Wafa Aoun, Karim Moreno, Javier Carrillo, Eugenia Salotra, Poonam Kaushal, Himanshu Negi, Narender Singh Arevalo, Jorge Falconi-Agapito, Francesca Privat, Angela Cruz, Maria Pagniez, Julie Papierok, Gérard-Marie Rhouma, Faten Bel Haj Torres, Pilar Lemesre, Jean-Loup Chenik, Mehdi Meddeb-Garnaoui, Amel |
author_sort | Chamakh-Ayari, Rym |
collection | PubMed |
description | PSA (Promastigote Surface Antigen) belongs to a family of membrane-bound and secreted proteins present in several Leishmania (L.) species. PSA is recognized by human Th1 cells and provides a high degree of protection in vaccinated mice. We evaluated humoral and cellular immune responses induced by a L. amazonensis PSA protein (LaPSA-38S) produced in a L. tarentolae expression system. This was done in individuals cured of cutaneous leishmaniasis due to L. major (CCLm) or L. braziliensis (CCLb) or visceral leishmaniasis due to L. donovani (CVLd) and in healthy individuals. Healthy individuals were subdivided into immune (HHR-Lm and HHR-Li: Healthy High Responders living in an endemic area for L. major or L. infantum infection) or non immune/naive individuals (HLR: Healthy Low Responders), depending on whether they produce high or low levels of IFN-γ in response to Leishmania soluble antigen. Low levels of total IgG antibodies to LaPSA-38S were detected in sera from the studied groups. Interestingly, LaPSA-38S induced specific and significant levels of IFN-γ, granzyme B and IL-10 in CCLm, HHR-Lm and HHR-Li groups, with HHR-Li group producing TNF-α in more. No significant cytokine response was observed in individuals immune to L. braziliensis or L. donovani infection. Phenotypic analysis showed a significant increase in CD4+ T cells producing IFN-γ after LaPSA-38S stimulation, in CCLm. A high positive correlation was observed between the percentage of IFN-γ-producing CD4+ T cells and the released IFN-γ. We showed that the LaPSA-38S protein was able to induce a mixed Th1 and Th2/Treg cytokine response in individuals with immunity to L. major or L. infantum infection indicating that it may be exploited as a vaccine candidate. We also showed, to our knowledge for the first time, the capacity of Leishmania PSA protein to induce granzyme B production in humans with immunity to L. major and L. infantum infection. |
format | Online Article Text |
id | pubmed-4008367 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-40083672014-05-09 In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis Chamakh-Ayari, Rym Bras-Gonçalves, Rachel Bahi-Jaber, Narges Petitdidier, Elodie Markikou-Ouni, Wafa Aoun, Karim Moreno, Javier Carrillo, Eugenia Salotra, Poonam Kaushal, Himanshu Negi, Narender Singh Arevalo, Jorge Falconi-Agapito, Francesca Privat, Angela Cruz, Maria Pagniez, Julie Papierok, Gérard-Marie Rhouma, Faten Bel Haj Torres, Pilar Lemesre, Jean-Loup Chenik, Mehdi Meddeb-Garnaoui, Amel PLoS One Research Article PSA (Promastigote Surface Antigen) belongs to a family of membrane-bound and secreted proteins present in several Leishmania (L.) species. PSA is recognized by human Th1 cells and provides a high degree of protection in vaccinated mice. We evaluated humoral and cellular immune responses induced by a L. amazonensis PSA protein (LaPSA-38S) produced in a L. tarentolae expression system. This was done in individuals cured of cutaneous leishmaniasis due to L. major (CCLm) or L. braziliensis (CCLb) or visceral leishmaniasis due to L. donovani (CVLd) and in healthy individuals. Healthy individuals were subdivided into immune (HHR-Lm and HHR-Li: Healthy High Responders living in an endemic area for L. major or L. infantum infection) or non immune/naive individuals (HLR: Healthy Low Responders), depending on whether they produce high or low levels of IFN-γ in response to Leishmania soluble antigen. Low levels of total IgG antibodies to LaPSA-38S were detected in sera from the studied groups. Interestingly, LaPSA-38S induced specific and significant levels of IFN-γ, granzyme B and IL-10 in CCLm, HHR-Lm and HHR-Li groups, with HHR-Li group producing TNF-α in more. No significant cytokine response was observed in individuals immune to L. braziliensis or L. donovani infection. Phenotypic analysis showed a significant increase in CD4+ T cells producing IFN-γ after LaPSA-38S stimulation, in CCLm. A high positive correlation was observed between the percentage of IFN-γ-producing CD4+ T cells and the released IFN-γ. We showed that the LaPSA-38S protein was able to induce a mixed Th1 and Th2/Treg cytokine response in individuals with immunity to L. major or L. infantum infection indicating that it may be exploited as a vaccine candidate. We also showed, to our knowledge for the first time, the capacity of Leishmania PSA protein to induce granzyme B production in humans with immunity to L. major and L. infantum infection. Public Library of Science 2014-05-02 /pmc/articles/PMC4008367/ /pubmed/24786587 http://dx.doi.org/10.1371/journal.pone.0092708 Text en © 2014 Chamakh-Ayari et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Chamakh-Ayari, Rym Bras-Gonçalves, Rachel Bahi-Jaber, Narges Petitdidier, Elodie Markikou-Ouni, Wafa Aoun, Karim Moreno, Javier Carrillo, Eugenia Salotra, Poonam Kaushal, Himanshu Negi, Narender Singh Arevalo, Jorge Falconi-Agapito, Francesca Privat, Angela Cruz, Maria Pagniez, Julie Papierok, Gérard-Marie Rhouma, Faten Bel Haj Torres, Pilar Lemesre, Jean-Loup Chenik, Mehdi Meddeb-Garnaoui, Amel In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis |
title |
In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis |
title_full |
In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis |
title_fullStr |
In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis |
title_full_unstemmed |
In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis |
title_short |
In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis |
title_sort | in vitro evaluation of a soluble leishmania promastigote surface antigen as a potential vaccine candidate against human leishmaniasis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008367/ https://www.ncbi.nlm.nih.gov/pubmed/24786587 http://dx.doi.org/10.1371/journal.pone.0092708 |
work_keys_str_mv | AT chamakhayarirym invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT brasgoncalvesrachel invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT bahijabernarges invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT petitdidierelodie invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT markikououniwafa invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT aounkarim invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT morenojavier invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT carrilloeugenia invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT salotrapoonam invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT kaushalhimanshu invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT neginarendersingh invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT arevalojorge invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT falconiagapitofrancesca invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT privatangela invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT cruzmaria invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT pagniezjulie invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT papierokgerardmarie invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT rhoumafatenbelhaj invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT torrespilar invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT lemesrejeanloup invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT chenikmehdi invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis AT meddebgarnaouiamel invitroevaluationofasolubleleishmaniapromastigotesurfaceantigenasapotentialvaccinecandidateagainsthumanleishmaniasis |